Antidepressant's true suicide risk hidden for years

There are renewed concerns over the safety of an antidepressant for adolescents following the reanalysis of decade-old trial data by Australian researchers.

The study of paroxetine's original clinical trial data, published on Thursday, shows that the manufacturer-funded analysis contains major flaws, including incorrect statistical models and failure to include all adverse events.

The reanalysis — carried out by researchers from Australia, North America and the UK —